Cryoimmunotherapy: Superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod

Archives of Dermatology

Volumn 147, Issue 11, 2011, Pages 1326-1327

  MacFarlane, Deborah F ^a,b   El Tal, Abdel Kader ^a  

^a University of Texas Health Science Center at Houston   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; LIQUID NITROGEN; RETINOIC ACID;

ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; CONSTITUTIONAL SYMPTOM; CONTROLLED STUDY; CRYOIMMUNOTHERAPY; CRYOTHERAPY; DRUG PENETRATION; ELASTOSIS; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PHYSICAL DISEASE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN CANCER; SKIN ULCER; SQUAMOUS CELL CARCINOMA IN SITU; SUPERFICIAL BASAL CELL CANCER; SUPERFICIAL CANCER; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CRYOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; MALE; NITROGEN; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 81855190643     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.334     Document Type: Article

References (6)

1. Holt PJ. Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol. 1988;119(2):231-240.
2. Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg. 2003;29(6):566-571. (Pubitemid 36702438)
3. Quirk C, Gebauer K, De'Ambrosis B, Slade HB, Meng TC. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis. 2010;85(6):318-324.
4. Gollnick H, Barona CG, Frank RG, et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod5%cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol. 2008;18(6):677-682.
5. Rosen T, Harting M, Gibson M. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. Dermatol Surg. 2007;33(4):427-432.
6. Patel GK, Goodwin R, Chawla M, et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2006;54(6):1025- 1032.